A treatment regimen which is individually tailored to the individual patient's needs should be developed by the attending physician and the achievement of the set objectives should be monitored at regular intervals. However, restrictions induced by patients due to inadequate adherence or by the drug due to limited efficacy of the drug have to be considered. Therefore, eye drop therapy in open-angle glaucoma is not always sufficient. It should be supplemented in due time by laser or filtering surgery before the affected patients and their optic nerves suffer advanced glaucomatous damage.

Involutive changes in the collagen and muscular structures of the lower lid in ageing may lead to the formation of senile entropium. Treatment of this condition may be achieved using botulinum toxin injections to the dislocated orbicularis muscle. These injections lead to cessation of the symptoms for a mean of 3.8 months. Repeat injections are possible. Botulinum toxin injections are a viable option for patients who are not amenable to surgical correction of the entropium.

No abstract